Validation that INVU is Comparable to SoC for fHR
The following summary provides a high-level overview of a peer-reviewed study describing a wireless, remote, self-administered solution for fetal and maternal heart rate monitoring.
Background:
Access to prenatal care can be limited due to physician shortages and geographic barriers, particularly in rural areas. The need for repeated in-clinic visits to collect basic fetal measurements places a significant burden on patients. Current standard-of-care fetal monitoring, based on external cardiotocography, must be performed by trained medical professionals in a healthcare setting. These limitations highlight the need for remote, self-administered fetal monitoring solutions that can reduce barriers to care.
Objective:
The objective of this study was to compare fetal heart rate (FHR) and maternal heart rate (MHR) measurements obtained using the Invu system, a wireless, wearable, self-administered device to those obtained using cardiotocography, with the goal of enabling a true remote fetal monitoring solution.
Results:
1. Participants: 147 women; mean maternal age 31.8 years; mean gestational age 37.7 weeks.
2. Fetal heart rate:
2.1. Strong correlation between Invu and cardiotocography measurements (r = 0.92, P<0.0001).
2.2. 95% limits of agreement ranged from –8.84 bpm to 8.24 bpm.
3. Maternal heart rate:
Very strong correlation between Invu and cardiotocography (r = 0.97, P<0.0001).
4. Safety:
No adverse events were reported during the study.
Conclusion:
-
Wireless, remote solution for home fetal and maternal heart rate monitoring
-
American Journal of Obstetrics & Gynecology 2020